The successful closure of the inspection further strengthens Strides' regulatory track record and reinforces the company's commitment to supplying high-quality pharma products to patients across globe
The successful closure of the inspection further strengthens Strides' regulatory track record and reinforces the company's commitment to supplying high-quality pharma products to patients across globe
<iframe src="https://hindustansphere.com/embed/cluster/a525b7a6a4891a8b7695f1df4044cdad46d7ba51" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Strides Pharma surges 11% on USFDA EIR for flagship facility in Bengaluru"></iframe>
